Ken Itrato

General corporate and transactional law

• WilmerHale
• Foley Hoag, LLP

Private Financing

Recent Company-side Equity Financings of:

• Aerium Therapeutics, Inc.
• Brillouin Energy, Inc.
• Gleason Technology, Inc.
• Liteboxer, Inc.
• Micropsi Industries GmbH
• Mnemo Therapeutics, SAS
• Muzooka, Inc.
• Neroshield, Inc.
• Apic Bio, Inc.
• Artax Biopharma, Inc.
• AnTolRx, Inc.
• Blue Oak Pharmaceuticals, Inc.
• Increvet, Inc.
• Lysosomal Therapeutics, Inc.
• AuthAir, Inc.
• Codiscope, LLC
• Gleason Technology
• Juliet Marine Systems, Inc.
• PIC Therapeutics, Inc.
• Summation Bio, Inc.
• Synqy, Inc.
• Theragnostics Ltd.
• Vizgen, Inc.

Recent Investor-side Equity Financings:

• 5AM Ventures of Arvinas, Aurora Bio, Inc., Chrono Therapeutics, Inc., Cycloporters, Disc Medicines, Inc. EnLiven Therapeutics, Entrada, Escient Pharmaceuticals, Expansion Therapeutics, Georgiamune, Inc., Ideaya Biosciences, Impel Neuropharma, Karius, Inc., Kinaset, Inc., Latigo, Inc., Maplight Therapeutics, Inc., Nido Biosciences, Inc. Nodthera, Pear Therapeutics, Portal Instruments, Purigen Bio, RareCyte, Inc., Scientics.com, Inc., Tectonic, Inc., TMRW Life Sciences, and VOR Biopharma, Inc.
• Advanced Technology Ventures, Inc. of Artax Biopharma, Inc. and Aleta, Inc.
• Arboretum Ventures of undisclosed portfolio company
• Columbus Venture Partners of Aleta BioTherapeutics, Inc.
• Delos Capital of Zenas BioPharma, Inc.
• Family Office interests in Biolumen, Compass Beauty, FitBiomics, HBox, Jesmond Venture, Juvenescence, Majestic, Menwell, Mixlab, Optimeos, Luca Biologics, Pendulum (Wholebiome), Red Maple, Seed Health, Solarea, Sonoma Brands, Symbiome, Syocin, Ubiome, Weiss Bio, US Data Mining Corp.
• Flare Capital Partners of Annum Health, Inc.
• GIMV NV of Kinaset, Inc.
• Orbimed Advisors LLC
• Termeer family office of Advent Life Sciences, Aleta Therapeutics, Amylyx, Chrysalis Genetics, and X4 Pharma
• 5AM Ventures of Arvinas, Cycloporters, EnLiven Therapeutics, Escient Pharmaceuticals, Expansion Therapeutics, Georgiamune, Inc., Ideaya Biosciences, Impel Neuropharma, Nodthera, Pear Therapeutics, Portal Instruments, Purigen Bio, and TMRW Life Sciences,
• Private investors of Beme, Inc., Digital Animal PLC, GCM-MIR, LLC, Jetaport, Inc., MyLockBox, Inc., Plyfe, Inc., Pop and Bottle, Inc., Printi, LLC, Retail MLS, LLC, StarTek, LLC, Swaggable, Inc., and Urban Compass, Inc.
• Advent Life Sciences of Artax Biopharma, Inc.
• Accomplice, various investments
• Epidarex Capital of Nothera Ltd.
• Private Investor of X4 Pharmaceuticals and Artax Biopharma, Inc.
• Lilly Ventures of Hydra Biosciences, Inc.
• Lime Street Ventures of Volta Networks, Inc.
• MVM Partners LLP
• NOGRA Group of Elysium Health
• .406 Ventures of CloudPercept, Rapid Focus, Terbium Labs, Inc., Trilio Data and others
• Advanced Technology Ventures of Hydra Biosciences, Inc.
• Cubist Pharmaceuticals, Inc. of Forma Therapeutics

Debt and venture debt financings:

• Project financing by private investor of BioStar, LLC, Eco Plexus, Xtreme Power, Blue Bird, LLP, and Advanced Building Products
• JENTEK Sensors
• Various Clients by Silicon Valley Bank

Strategic Transactions/M&A

Acquisition, Sale or Option of:

• Palette Life Sciences, Inc. to Teleflex Corporation
• Arbor Biotechnologies, Inc. acquisition of undisclosed
• Arxspan, Inc. to Bruker Company
• Straight Shot Solutions, Inc. to undisclosed
• Theragnostics, Inc. to Ariceum
• Casco Media Corp. sale of substantially all of its assets to RELX Group
• Codiscope, LLC
• DMWare, Inc. to Certica Systems, Inc.
• Faria Watchdog, Inc.
• Goodwin Group International to SAGE Inc.
• HighRes Biosolutions, Inc. to Axel Johnson, Inc.
• Immunogen (product-line sale)
• Jisto, Inc. (investor interests)
• Lysosomal Therapeutics, Inc.
• Parking Edge, LLC to ParkWhiz, Inc.
• PoroGen Corporation (controlling interest to private investor)
• PoroGen Corporation to Air Liquide SA
• Profit Tools, Inc.
• Sheffield Pharmaceuticals, Inc. (multiple product lines)
• Smiths Detection (certain assets) to Vizsafe, Inc.
• UberTags, LLC to X+2, Inc.
• VGo Communications, Inc. to Vecna Technologies, Inc.

Ken has been active in various professional and community activities. He served as a mentor for the MIT $100K and ICE business plan competitions and as an advisor to CCTEC, the technology licensing office of Cornell University. Ken has also served on the Cornell University Life Sciences Board and worked with the university’s Entrepreneurial Network, as well as the Dartmouth Entrepreneurial Network. He is a member of the Cambridge Boat Club and Lowell’s Boat Shop.